Qube Research & Technologies (QRT)
SMMT icon

Qube Research & Technologies (QRT)’s Summit Therapeutics SMMT Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-34,906
Closed -$61.1K – 2962
2023
Q1 		$61.1K Buy
+34,906
New +$95.2K ﹤0.01% 2205
2022
Q4 		– Sell
-17,120
Closed -$20K – 2949
2022
Q3 		$20K Sell
17,120
-1,691
-9% -$1.91K ﹤0.01% 2301
2022
Q2 		$19K Buy
+18,811
New +$26.4K ﹤0.01% 2273

Other funds holding SMMT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SPIA
Steward Partners Investment Advisory New York $19.6B AUM 22.89% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Qube Research & Technologies (QRT)'s SMMT Position: Q2 2023 in Review

Qube Research & Technologies (QRT) sold out of Summit Therapeutics (SMMT) in Q2 2023, closing a stake of 34,906 shares — an estimated $61.1K sold.

Qube Research & Technologies (QRT) first reported a position in SMMT in Q2 2022 and held it in 3 quarters. The position peaked at $61.1K in Q1 2023. 100 funds tracked by Wall St. Rank hold SMMT as of Q2 2023.

  • Qube Research & Technologies (QRT) reported no remaining Summit Therapeutics position as of Q2 2023 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 34,906 Summit Therapeutics shares in Q2 2023, an estimated $61.1K.
  • Qube Research & Technologies (QRT) first reported a position in Summit Therapeutics in Q2 2022 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Summit Therapeutics position peaked at $61.1K in Q1 2023.
  • 100 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2023.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2023, filed 14 Aug 2023.